219 related articles for article (PubMed ID: 29389596)
1. Flavonoid compounds as reversing agents of the P-glycoprotein-mediated multidrug resistance: An in vitro evaluation with focus on antiepileptic drugs.
Ferreira A; Rodrigues M; Fortuna A; Falcão A; Alves G
Food Res Int; 2018 Jan; 103():110-120. PubMed ID: 29389596
[TBL] [Abstract][Full Text] [Related]
2. In vitro screening of dual flavonoid combinations for reversing P-glycoprotein-mediated multidrug resistance: Focus on antiepileptic drugs.
Ferreira A; Santos AO; Falcão A; Alves G
Food Chem Toxicol; 2018 Jan; 111():84-93. PubMed ID: 29122665
[TBL] [Abstract][Full Text] [Related]
3. The antiepileptic drug lamotrigine is a substrate of mouse and human breast cancer resistance protein (ABCG2).
Römermann K; Helmer R; Löscher W
Neuropharmacology; 2015 Jun; 93():7-14. PubMed ID: 25645391
[TBL] [Abstract][Full Text] [Related]
4. Knockout of P-glycoprotein does not alter antiepileptic drug efficacy in the intrahippocampal kainate model of mesial temporal lobe epilepsy in mice.
Bankstahl M; Klein S; Römermann K; Löscher W
Neuropharmacology; 2016 Oct; 109():183-195. PubMed ID: 27288003
[TBL] [Abstract][Full Text] [Related]
5. In vitro assessment of the interactions of dopamine β-hydroxylase inhibitors with human P-glycoprotein and Breast Cancer Resistance Protein.
Bicker J; Alves G; Fortuna A; Soares-da-Silva P; Falcão A
Eur J Pharm Sci; 2018 May; 117():35-40. PubMed ID: 29428540
[TBL] [Abstract][Full Text] [Related]
6. Silymarin as a flavonoid-type P-glycoprotein inhibitor with impact on the pharmacokinetics of carbamazepine, oxcarbazepine and phenytoin in rats.
Ferreira A; Rodrigues M; Meirinho S; Fortuna A; Falcão A; Alves G
Drug Chem Toxicol; 2021 Sep; 44(5):458-469. PubMed ID: 31020859
[TBL] [Abstract][Full Text] [Related]
7. Influence of the dual combination of silymarin and (-)-epigallocatechin gallate, natural dietary flavonoids, on the pharmacokinetics of oxcarbazepine in rats.
Ferreira A; Rodrigues M; Marques A; Falcão A; Alves G
Food Chem Toxicol; 2017 Aug; 106(Pt A):446-454. PubMed ID: 28602600
[TBL] [Abstract][Full Text] [Related]
8. Aristolochic acid I is a substrate of BCRP but not P-glycoprotein or MRP2.
Ma L; Qin Y; Shen Z; Bi H; Hu H; Huang M; Zhou H; Yu L; Jiang H; Zeng S
J Ethnopharmacol; 2015 Aug; 172():430-5. PubMed ID: 26183576
[TBL] [Abstract][Full Text] [Related]
9. Drug-protein hydrogen bonds govern the inhibition of the ATP hydrolysis of the multidrug transporter P-glycoprotein.
Chufan EE; Kapoor K; Ambudkar SV
Biochem Pharmacol; 2016 Feb; 101():40-53. PubMed ID: 26686578
[TBL] [Abstract][Full Text] [Related]
10. Effects of MDR1 (C3435T) Polymorphism on Resistance, Uptake, and Efflux to Antiepileptic Drugs.
Shen XM; Cheng J
DNA Cell Biol; 2019 Mar; 38(3):250-255. PubMed ID: 30632789
[TBL] [Abstract][Full Text] [Related]
11. Structure affinity relationship and docking studies of flavonoids as substrates of multidrug-resistant associated protein 2 (MRP2) in MDCK/MRP2 cells.
Fang Y; Cao W; Liang F; Xia M; Pan S; Xu X
Food Chem; 2019 Sep; 291():101-109. PubMed ID: 31006447
[TBL] [Abstract][Full Text] [Related]
12. Characterization and Validation of Canine P-Glycoprotein-Deficient MDCK II Cell Lines for Efflux Substrate Screening.
Ye D; Harder A; Fang Z; Weinheimer M; Laplanche L; Mezler M
Pharm Res; 2020 Sep; 37(10):194. PubMed ID: 32918191
[TBL] [Abstract][Full Text] [Related]
13. In vitro transport profile of carbamazepine, oxcarbazepine, eslicarbazepine acetate, and their active metabolites by human P-glycoprotein.
Zhang C; Zuo Z; Kwan P; Baum L
Epilepsia; 2011 Oct; 52(10):1894-904. PubMed ID: 21692796
[TBL] [Abstract][Full Text] [Related]
14. Global alteration of the drug-binding pocket of human P-glycoprotein (ABCB1) by substitution of fifteen conserved residues reveals a negative correlation between substrate size and transport efficiency.
Vahedi S; Chufan EE; Ambudkar SV
Biochem Pharmacol; 2017 Nov; 143():53-64. PubMed ID: 28728917
[TBL] [Abstract][Full Text] [Related]
15. Structure-activity relationships of the inhibitory effects of flavonoids on P-glycoprotein-mediated transport in KB-C2 cells.
Kitagawa S; Nabekura T; Takahashi T; Nakamura Y; Sakamoto H; Tano H; Hirai M; Tsukahara G
Biol Pharm Bull; 2005 Dec; 28(12):2274-8. PubMed ID: 16327165
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of potential herb-drug interactions between oseltamivir and commonly used anti-influenza Chinese medicinal herbs.
Zhang Y; Lyu C; Fong SYK; Wang Q; Li C; Ho NJ; Chan KS; Yan X; Zuo Z
J Ethnopharmacol; 2019 Oct; 243():112097. PubMed ID: 31325600
[TBL] [Abstract][Full Text] [Related]
17. Reversal Effect of Oxypeucedanin on P-glycoprotein-mediated Drug Transport.
Dong W; Liao ZG; Zhao GW; Guan XJ; Zhang J; Liang XL; Yang M
Molecules; 2018 Jul; 23(8):. PubMed ID: 30042338
[TBL] [Abstract][Full Text] [Related]
18. Differences in the transport of the antiepileptic drugs phenytoin, levetiracetam and carbamazepine by human and mouse P-glycoprotein.
Baltes S; Gastens AM; Fedrowitz M; Potschka H; Kaever V; Löscher W
Neuropharmacology; 2007 Feb; 52(2):333-46. PubMed ID: 17045309
[TBL] [Abstract][Full Text] [Related]
19. Multidrug resistance-associated protein 2 is involved in the efflux of Aconitum alkaloids determined by MRP2-MDCKII cells.
Dai P; Zhu L; Yang X; Zhao M; Shi J; Wang Y; Lu L; Liu Z
Life Sci; 2015 Apr; 127():66-72. PubMed ID: 25744397
[TBL] [Abstract][Full Text] [Related]
20. Do ATP-binding cassette transporters cause pharmacoresistance in epilepsy? Problems and approaches in determining which antiepileptic drugs are affected.
Löscher W; Luna-Tortós C; Römermann K; Fedrowitz M
Curr Pharm Des; 2011; 17(26):2808-28. PubMed ID: 21827408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
